Related Experiment Video
Updated: May 17, 2026

A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
RhTFAM treatment stimulates mitochondrial oxidative metabolism and improves memory in aged mice
Ravindar R Thomas1, Shaharyar M Khan, Rafal M Smigrodzki
1Parkinson's Disease Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
Abstract:
Mitochondrial function declines with age in postmitotic tissues such as brain, heart and skeletal muscle. Despite weekly exercise, aged mice showed substantial losses of mtDNA gene copy numbers and reductions in mtDNA gene transcription and mitobiogenesis signaling in brain and heart. We treated these mice with weekly intravenous injections of recombinant human mitochondrial transcription factor A (rhTFAM). RhTFAM treatment for one month increased mitochondrial respiration in brain, heart and muscle, POLMRT expression and mtDNA gene transcription in brain, and PGC-1 alpha mitobiogenesis signaling in heart. RhTFAM treatment reduced oxidative stress damage to brain proteins, improved memory in Morris water maze performance and increased brain protein levels of BDNF and synapsin. Microarray analysis showed co-expression of multiple Gene Ontology families in rhTFAM-treated aged brains compared to young brains. RhTFAM treatment reverses age-related memory impairments associated with loss of mitochondrial energy production in brain, increases levels of memory-related brain proteins and improves mitochondrial respiration in brain and peripheral tissues.
Insights
Recombinant human mitochondrial transcription factor A (rhTFAM) treatment reversed age-related mitochondrial decline and memory loss in aged mice. This intervention improved brain function and mitochondrial respiration in multiple tissues.
Area of Science:
- Mitochondrial biology
- Neuroscience
- Aging research
Background:
- Mitochondrial function declines with age in vital tissues like the brain, heart, and skeletal muscle.
- Even with exercise, aged mice exhibit reduced mitochondrial DNA (mtDNA) copy numbers and gene transcription, alongside diminished mitobiogenesis signaling in the brain and heart.
Purpose of the Study:
- To investigate the therapeutic potential of recombinant human mitochondrial transcription factor A (rhTFAM) in counteracting age-related mitochondrial dysfunction and cognitive decline.
- To assess the impact of rhTFAM treatment on mitochondrial respiration, gene expression, and key signaling pathways in aged mice.
Main Methods:
- Aged mice were administered weekly intravenous injections of rhTFAM for one month.
- Mitochondrial respiration, gene transcription (POLRMT), mitobiogenesis signaling (PGC-1 alpha), oxidative stress markers, and levels of brain-derived neurotrophic factor (BDNF) and synapsin were measured.
- Cognitive function was evaluated using the Morris water maze test.
- Microarray analysis was performed on brain tissue.
Main Results:
- rhTFAM treatment significantly enhanced mitochondrial respiration in the brain, heart, and skeletal muscle.
- The treatment increased POLRMT expression and mtDNA gene transcription in the brain, and boosted PGC-1 alpha signaling in the heart.
- rhTFAM reduced oxidative stress in the brain, improved memory performance, and elevated BDNF and synapsin levels.
- Microarray analysis revealed coordinated gene expression patterns in rhTFAM-treated aged brains.
Conclusions:
- rhTFAM effectively reverses age-related memory impairments linked to mitochondrial energy deficits.
- The treatment enhances mitochondrial function and increases levels of crucial memory-associated proteins in the brain.
- rhTFAM demonstrates potential as a therapeutic agent for age-related cognitive decline and mitochondrial dysfunction.
More Related Videos
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer's Disease: Treatment
Mitochondria